Received Aug 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | Y97N7 | — |
Infanrix instead of Boostrix to a 13-year-old patient; administering Infanrix to a 13-year-old patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 13-year-old male patient who received DTPa (Infanrix) (batch number Y97N7, expiry date 29-JUL-2025) for prophylaxis. Co-suspect products included DTPa (Reduced antigen) (Boostrix) for prophylaxis. On 29-JUL-2025, the patient received Infanrix. The patient did not receive Boostrix. On 29-JUL-2025, an unknown time after receiving Infanrix, the patient experienced wrong vaccine administered (Verbatim: Infanrix instead of Boostrix to a 13-year-old patient) and inappropriate age at vaccine administration (Verbatim: administering Infanrix to a 13-year-old patient). The outcome of the wrong vaccine administered and inappropriate age at vaccine administration were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 29-JUL-2025 Health Care Provider wanted to know how to proceed after administering Infanrix instead of Boostrix to a 13-year-old patient, which led to wrong vaccine administered and inappropriate age at vaccine administration.